AU2003298708A1 - GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER - Google Patents

GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER

Info

Publication number: AU2003298708A1
Authority: AU; Australia
Prior art keywords: gpc99a; gpc99; compositions; methods; treating cancer
Prior art date: 2002-11-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003298708A

Other versions

AU2003298708A8 (en

Inventor

Karuppiah Kannan

Ronan C. O'hagan

Rijian Wang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aveo Pharmaceuticals Inc

Original Assignee

Genpath Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-27

Filing date

2003-11-26

Publication date

2004-06-23

2003-11-26 Application filed by Genpath Pharmaceuticals Inc filed Critical Genpath Pharmaceuticals Inc

2004-06-23 Publication of AU2003298708A8 publication Critical patent/AU2003298708A8/en

2004-06-23 Publication of AU2003298708A1 publication Critical patent/AU2003298708A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2003298708A 2002-11-27 2003-11-26 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER Abandoned AU2003298708A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42987702P	2002-11-27	2002-11-27
US60/429,877		2002-11-27
PCT/US2003/037813 WO2004050834A2 (en)	2002-11-27	2003-11-26	GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER

Publications (2)

Publication Number	Publication Date
AU2003298708A8 AU2003298708A8 (en)	2004-06-23
AU2003298708A1 true AU2003298708A1 (en)	2004-06-23

Family

ID=32469383

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003298708A Abandoned AU2003298708A1 (en)	2002-11-27	2003-11-26	GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER

Country Status (2)

Country	Link
AU (1)	AU2003298708A1 (en)
WO (1)	WO2004050834A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0521139D0 (en) *	2005-10-18	2005-11-23	Univ Sheffield	Therapeutic agent
GB0708002D0 (en)	2007-04-25	2007-06-06	Univ Sheffield	Antibodies
JP5099856B2 (en) *	2007-11-26	2012-12-19	独立行政法人科学技術振興機構	Metabolic syndrome treatment or prevention agent, test method, test drug, and screening method for candidate compound of metabolic syndrome treatment drug
CA3075867A1 (en) *	2017-09-13	2019-03-21	Gene Techno Science Co., Ltd.	Anti-ramp2 antibody
CN110090297B (en) *	2019-03-29	2021-05-14	中国人民解放军陆军军医大学第一附属医院	Use of ADM competitive antagonist AMA in glioma immunotherapy
CN110075276A (en) *	2019-03-29	2019-08-02	中国人民解放军陆军军医大学第一附属医院	Application of the ADM competitive antagonist AMA in anti-glioma angiogenesis treatment
GB202303531D0 (en) *	2023-03-10	2023-04-26	Fusion Antibodies Plc	Antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2315702A1 (en) *	1997-12-24	1999-07-08	Immunex Corporation	V196 dna and polypeptides

2003
- 2003-11-26 WO PCT/US2003/037813 patent/WO2004050834A2/en not_active Ceased
- 2003-11-26 AU AU2003298708A patent/AU2003298708A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003298708A8 (en)	2004-06-23
WO2004050834A2 (en)	2004-06-17
WO2004050834A3 (en)	2004-12-02

Similar Documents

Publication	Publication Date	Title
AU2003230750A1 (en)	2003-10-13	Compositions and methods for treating cancer
EP2671581B8 (en)	2019-11-13	Compositions and methods for treating cancer
AU2003293194A1 (en)	2004-06-23	Compositions and methods for treating prostate cancer
AU2003225535A1 (en)	2003-09-02	Methods and compositions for treating cancer
AU2003284242A1 (en)	2004-05-04	Methods and compositions for use in treating cancer
WO2003073826A8 (en)	2005-04-28	Novel compositions and methods for cancer
AU2003291356A1 (en)	2004-06-03	Methods and compositions for treating cancer using proteasome inhibitors
AU2003226301A1 (en)	2003-10-20	Method of treating cancer
AU2003243373A1 (en)	2003-12-19	Cell migration inhibiting compositions and methods and compositions for treating cancer
AU2003256847A1 (en)	2004-02-16	Method of treating cancer
AU2002364708A1 (en)	2003-06-10	Novel compositions and methods for cancer
AU2003297573A1 (en)	2004-06-23	Compositions and methods for treating transplants
AU2003212850A1 (en)	2003-09-02	Methods and compositions for treating cardiovascular disease
AU2003219160A1 (en)	2004-09-30	Methods and compositions for the treatment of cancer
AU2003238905A1 (en)	2003-12-22	Surface treating compositions and methods for using same
AU2003259202A1 (en)	2004-02-09	Compositions and methods for treating and preventing infection
AU2003298708A1 (en)	2004-06-23	GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER
AU2002337943A1 (en)	2003-05-06	Novel compositions and methods for cancer
AU2002337713A1 (en)	2003-04-07	Pharmaceutical compositions and methods for treating cancer
AU2003275433A1 (en)	2004-05-04	Compositions and methods for treating pain
EP1587405A4 (en)	2007-05-09	Novel compositions and methods for cancer
AU2003291730A1 (en)	2004-06-07	Methods and compositions for treating neurodegenerative diseases
AU2003300171A1 (en)	2004-07-29	Compositions and methods for treating lung cancer
AU2003295604A1 (en)	2004-06-03	Gpc15: methods and compositions for treating cancer
AU2002360454A1 (en)	2003-06-10	Methods and compositions for treating cancer

Legal Events

Date	Code	Title	Description
2005-09-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase